Bristol Myers to invest $40 billion in the U.S. over 5 years
On May 5, 2025, Bristol Myers Squibb said it will invest $40 billion in the U.S. over the…
-
-
Norovirus outbreak infected over 240 people on month-long luxury cruise
On Apr. 2, 2025, Cunard announced a norovirus outbreak had occurred aboard a luxury cruise ship that struck…
-
Atlas of Brain’s Mitochondria Reveals High Cognition Areas Supplied with More Energy
On Mar. 26, 2025, researchers from Columbia University announced they have created MitoBrainMap, the first-ever atlas of the…
-
First hormone-free male birth control pill clears another milestone
On Mar. 26, 2025, research from the University of Minnesota College of Pharmacy, published in Communications Medicine, laid…
-
Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement
On Mar. 19, 2025, Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan, a major step towards finalizing a…
-
New York State Department of Health Reported First Case of Measles in New York State Outside of New York City in 2025
On Mar. 11, 2025, the New York State Department of Health today announced the first case of measles…
-
Bacterial ‘jumping genes’ can target and control chromosome ends
On Mar. 6, 2025, Cornell researchers announced they have discovered a new mechanism that genes use to survive…
-
SIGA technologies’ TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
On Jan. 2, 2025, SIGA Technologies announced that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as…
-
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
On Oct. 22, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO® (Respiratory…
-
Study found Pandemic-Era Babies Do Not Have Higher Autism Risk
On Sept. 23, 2024, researchers from Columbia University reported that a study of Children born during the first…
-
Study Revealed How COVID-19 Infection Can Cause or Worsen Diabetes
On Sept. 13, 2024, researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the…
-
Pfizer and BioNTech Received U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
On Aug. 22, 2024, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had approved…
-
When it comes to DNA replication, humans and baker’s yeast are more alike than different
On Aug. 1, 2024, the Van Andel Institute reported that humans and baker’s yeast have more in common…
-
European Commission Approved Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
On Jul. 25, 2024, Pfizer announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX®…
-
Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
Cornell Study confirmed mammal-to-mammal avian flu spread
On Jul. 24, 2024, a team led by researchers at Cornell University announced a study that provides evidence…
-
SIGA announced U.S. Government procurement orders of approximately $138 million for oral and IV TPOXX
On Jul. 19, 2024, SIGA Technologies announced that the U.S. Department of Health and Human Services exercised procurement…
-
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Vaccine | Women's Health
Late-pregnancy RSV vaccination not associated with poor birth outcomes
On Jul. 8, 2024, a study reported that babies exposed to maternal RSV (respiratory syncytial virus) vaccination in…
-
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
On Jul. 3, 2024, Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has approved Dupixent® (dupilumab)…
-
How a few days in space can disrupt a person’s biology
On Jun. 12, 2024, scientists at Weill Cornell Medicine in New York City reported that just a few…
-
Break the Habit!
“Break the Habit!,” A quit smoking poster published by the New York State Department of Health, 1989.
-
First-ever combined heart pump & gene-edited pig kidney transplant gives new hope to patient with terminal illness
On Apr. 24, 2024, surgeons at New York University Langone Health announced they had performed the first combined…
-
Agriculture | Biotechnology | Diagnostics | FDA | Infectious Disease | Influenza | Therapeutics | USDA | Vaccine
FDA reported commercial milk supply is safe with investigation of outbreak of HPAI virus ongoing
On Apr. 23, 2024, the U.S. Food and Drug Administration (FDA) announced that nearly all (99%) of the…
-
Otsuka and Click Therapeutics announce FDA clearance of Rejoyn, first prescription digital therapeutic for MDD
On Apr. 1, 2024, Otsuka Pharmaceutica and Click Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
-
Surgeons in New York announced world’s first eye transplant
On Nov. 10, 2023, surgeons in New York announced they had performed the first-ever whole-eye transplant in a…
-
Pfizer and BioNTech received U.S. FDA approval for 2023-2024 COVID-19 vaccine
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
-
COVID-19 | FDA | Infectious Disease | Vaccine
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
-
U.S. FDA approved ABRYSVO, Pfizer’s vaccine for prevention of RSV in infants through active immunization of pregnant Individuals
On Aug. 21, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
-
Pig kidney xenotransplantation performed optimally after 32 days in human body
On Aug. 16, 2023, surgeons at NYU Langone Health announced they had transplanted a genetically engineered pig kidney…
-
U.S. FDA approved Ervebo first U.S.-licensed vaccine for prevention of Ebola virus disease
On Dec. 20, 2019, Merck announced that the U.S. Food and Drug Administration (FDA) had approved ERVEBO® (Ebola…
-
Feinstein Institutes researchers first to use double neural bypass to restore movement in man living with quadriplegia
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Health’s…
